Harbour BioMed
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd Ste 355, Natick, Massac...Phone Number
(617) 682-3679Website
www.harbourbiomed.comRevenue
$89.5 MillionStock Symbol
2142.HKIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Harbour BioMed
Harbour BioMed is a global, clinical-stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Harbour BioMed was founded in 2016 and is headquartered in Massachusetts.Explore more
Harbour BioMed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Harbour BioMed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Harbour BioMed has recently received funding, and reach out quickly before it becomes old news!
Click to see if Harbour BioMed had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Harbour BioMed has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Harbour BioMed recently announced quarterly report
Check out if Harbour BioMed is spiking on competitors!
Product Launch: Get notified when Harbour BioMed launches new products
Harbour BioMed, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Harbour BioMed
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Harbour BioMed
Compare insights from companies similar to Harbour BioMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Harbour BioMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Harbour BioMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Harbour BioMed.
Harbour BioMed financials insights
Gather financial insights about Harbour BioMed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$75M
Series C
$102.8M
Harbour BioMed Tech Stack
A closer look at the technologies used by Harbour BioMed
Most Recent Scoops
Project
Intellectual Property, Lawsuits, Legal Affairs, Settlement
Project
Product Development, Legal Affairs, Safety, Medical Research, Pharmaceuticals, Clinical Operations, Regulations
Project
Spending/Investment
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Harbour BioMed News & Media
Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today announced that it has entered into a strategic collaboration with China National Pharmaceutical Group Co., Ltd. ("Sinopharm"). The two parties will establish the Sinopharm - Harbour BioMed Innovation Consortium (the "Innovation CHarbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 23, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, today...Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy
The antibody uses a dual mechanism of action and works to block the interaction between TSLP and its receptor.Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other areas, and Kelun-Biotech...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Harbour BioMed
Sign Up For FreeTo access detailed company insights
Harbour BioMed is a global, clinical-stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology and inflammatory diseases. Harbour BioMed was founded in 2016 and is headquartered in Massachusetts.... Read More
